{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:11:22Z","timestamp":1793236282832,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s12185-010-0577-x","type":"journal-article","created":{"date-parts":[[2010,4,30]],"date-time":"2010-04-30T03:20:17Z","timestamp":1272597617000},"page":"758-761","source":"Crossref","is-referenced-by-count":9,"title":["High frequency of MEFV gene mutations in patients with myeloid neoplasm"],"prefix":"10.1007","volume":"91","author":[{"given":"Cagatay","family":"Oktenli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozkan","family":"Sayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alev A.","family":"Erikci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Tunca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan M.","family":"Terekeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elcin Erkuvan","family":"Umur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavuz S.","family":"Sanisoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Torun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Tangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Sahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selim","family":"Nalbant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,1]]},"reference":[{"key":"577_CR1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1365-2249.2004.02632.x","volume":"138","author":"U Musabak","year":"2004","unstructured":"Musabak U, Sengul A, Oktenli C, Pay S, Yesilova Z, Kenar L, et al. Does immune activation continue during an attack-free period in familial Mediterranean fever? Clin Exp Immunol. 2004;138:526\u201333.","journal-title":"Clin Exp Immunol"},{"key":"577_CR2","first-page":"2024","volume":"35","author":"HM Terekeci","year":"2008","unstructured":"Terekeci HM, Oktenli C, Ozgurtas T, Nalbant S, Top C, Celik S, et al. Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF? J Rheumatol. 2008;35:2024\u20139.","journal-title":"J Rheumatol"},{"key":"577_CR3","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s00296-008-0648-y","volume":"28","author":"HM Terekeci","year":"2008","unstructured":"Terekeci HM, Ulusoy ER, Kucukarslan NM, Nalbant S, Oktenli C. Familial Mediterranean fever attacks do not alter functional and morphologic tissue Doppler echocardiographic parameters. Rheumatol Int. 2008;28:1239\u201343.","journal-title":"Rheumatol Int"},{"key":"577_CR4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng0997-25","volume":"17","author":"FMF The French","year":"1997","unstructured":"The French FMF. Consortium: a candidate gene for familial Mediterranean fever. Nat Genet. 1997;17:25\u201331.","journal-title":"Nat Genet"},{"key":"577_CR5","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0092-8674(00)80539-5","volume":"90","author":"FMF The International","year":"1997","unstructured":"The International FMF. Consortium: ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90:797\u2013807.","journal-title":"Cell"},{"key":"577_CR6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/QCO.0b013e328329d15e","volume":"22","author":"G Guz","year":"2009","unstructured":"Guz G, Kanbay M, Ozturk MA. Current perspectives on familial Mediterranean fever. Curr Opin Infect Dis. 2009;22:309\u201315.","journal-title":"Curr Opin Infect Dis"},{"key":"577_CR7","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/sj.ejhg.5200658","volume":"9","author":"I Touitou","year":"2001","unstructured":"Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet. 2001;9:473\u201383.","journal-title":"Eur J Hum Genet"},{"key":"577_CR8","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1182\/blood.V95.10.3223","volume":"95","author":"M Centola","year":"2000","unstructured":"Centola M, Wood G, Frucht DM, Galon J, Aringer M, Farrell C, et al. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood. 2000;95:3223\u201331.","journal-title":"Blood"},{"key":"577_CR9","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/rheumatology\/keh157","volume":"43","author":"G Grateau","year":"2004","unstructured":"Grateau G. Clinical and genetic aspects of the hereditary periodic fever syndromes. Rheumatology. 2004;43:410\u20135.","journal-title":"Rheumatology"},{"key":"577_CR10","first-page":"2070","volume":"34","author":"B Koc","year":"2007","unstructured":"Koc B, Oktenli C, Bulucu F, Karadurmus N, Sanisoglu SY, Gul D. The rate of pyrin mutations in critically ill patients with systemic inflammatory response syndrome and sepsis: a pilot study. J Rheumatol. 2007;34:2070\u20135.","journal-title":"J Rheumatol"},{"key":"577_CR11","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1084\/jem.20032234","volume":"200","author":"C Stehlik","year":"2004","unstructured":"Stehlik C, Reed JC. The PYRIN connection: novel players in innate immunity and inflammation. J Exp Med. 2004;200:551\u20138.","journal-title":"J Exp Med"},{"key":"577_CR12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1097-2765(03)00056-X","volume":"11","author":"JJ Chae","year":"2003","unstructured":"Chae JJ, Komarow HD, Cheng J, Wood G, Raben N, Liu PP, et al. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell. 2003;11:591\u2013604.","journal-title":"Mol Cell"},{"key":"577_CR13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0006-291X(03)00221-3","volume":"302","author":"TA Dowds","year":"2003","unstructured":"Dowds TA, Masumoto J, Chen FF, Ogura Y, Inohara N, Nunez G. Regulation of cryopyrin\/Pypaf1 signaling by pyrin, the familial Mediterranean fever gene product. Biochem Biophys Res Commun. 2003;302:575\u201380.","journal-title":"Biochem Biophys Res Commun"},{"key":"577_CR14","first-page":"S45","volume":"20","author":"DL Gumucio","year":"2002","unstructured":"Gumucio DL, Diaz A, Schaner P, Richards N, Babcock C, Schaller M, et al. Fire and ICE: the role of pyrin domain containing proteins in inflammation and apoptosis. Clin Exp Rheumatol. 2002;20:S45\u201353.","journal-title":"Clin Exp Rheumatol"},{"key":"577_CR15","doi-asserted-by":"crossref","first-page":"11570","DOI":"10.1074\/jbc.M112208200","volume":"277","author":"GA Manji","year":"2002","unstructured":"Manji GA, Wang L, Geddes BJ, Brown M, Merriam S, Al-Garawi A, et al. PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-kappa B. J Biol Chem. 2002;277:11570\u20135.","journal-title":"J Biol Chem"},{"key":"577_CR16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1042\/bj20030304","volume":"373","author":"C Stehlik","year":"2003","unstructured":"Stehlik C, Krajewska M, Welsh K, Krajewski S, Godzik A, Reed JC. The PAAD\/PYRIN-only protein POP1\/ASC2 is a modulator of ASC-mediated NF-\u03baB and pro-caspase-1 regulation. Biochem J. 2003;373:101\u201313.","journal-title":"Biochem J"},{"key":"577_CR17","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1084\/jem.20021552","volume":"196","author":"C Stehlik","year":"2002","unstructured":"Stehlik C, Fiorentino L, Dorfleutner A, Bruey JM, Ariza EM, Sagara J, et al. The PAAD\/PYRIN-family protein ASC is a dual regulator of a conserved step in nuclear factor kappaB activation pathways. J Exp Med. 2002;196:1605\u201315.","journal-title":"J Exp Med"},{"key":"577_CR18","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.bcp.2006.06.011","volume":"72","author":"A Keutgens","year":"2006","unstructured":"Keutgens A, Robert I, Viatour P, Chariot A. Deregulated NF-kB activity in haematological malignancies. Biochem Pharmacol. 2006;72:1069\u201380.","journal-title":"Biochem Pharmacol"},{"key":"577_CR19","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1182\/blood.V95.4.1451.004k52_1451_1455","volume":"95","author":"N Tidow","year":"2000","unstructured":"Tidow N, Chen X, Muller C, Kawano S, Gombart AF, Fischel-Ghodsian N, et al. Hematopoietic-specific expression of MEFV, the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin. Blood. 2000;95:1451\u20135.","journal-title":"Blood"},{"key":"577_CR20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12185-009-0336-z","volume":"90","author":"K Sasaki","year":"2009","unstructured":"Sasaki K, Tahara T, Mitani K. Presentation of familial Mediterranean fever in a heterozygous MEFV mutation triggered by immunosuppressive therapy for myelodysplastic syndrome. Int J Hematol. 2009;90:91\u20133.","journal-title":"Int J Hematol"},{"key":"577_CR21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000158578","volume":"120","author":"T Miyoshi","year":"2008","unstructured":"Miyoshi T, Yamashita K, Ohno T, Izumi T, Takaori-Kondo A, Sasada M, et al. Familial Mediterranean fever gene as a possible modifier of sweet syndrome with chronic myelogenous leukemia. Acta Haematol. 2008;120:57\u201362.","journal-title":"Acta Haematol"},{"key":"577_CR22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1532\/IJH97.03119","volume":"79","author":"Y Kotone-Miyahara","year":"2004","unstructured":"Kotone-Miyahara Y, Takaori-Kondo A, Fukunaga K, Goto M, Hayashino Y, Miki M, et al. E148Q\/M694I mutation in 3 Japanese patients with familial Mediterranean fever. Int J Hematol. 2004;79:235\u20137.","journal-title":"Int J Hematol"},{"key":"577_CR23","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10067-007-0780-1","volume":"27","author":"E Demirkaya","year":"2008","unstructured":"Demirkaya E, Tunca Y, Gok F, Ozen S, Gul D. A very frequent mutation and remarkable association of R761H with M694V mutations in Turkish familial Mediterranean fever patients. Clin Rheumatol. 2008;27:729\u201332.","journal-title":"Clin Rheumatol"},{"key":"577_CR24","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/sj.ejhg.5200674","volume":"9","author":"E Yilmaz","year":"2001","unstructured":"Yilmaz E, Ozen S, Balci B, Duzova A, Topaloglu R, Besbas N, et al. Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet. 2001;9:553\u20135.","journal-title":"Eur J Hum Genet"},{"key":"577_CR25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10555-006-9004-4","volume":"25","author":"RN Apte","year":"2006","unstructured":"Apte RN, Dotan S, Elkabets M, White MR, Reich E, Carmi Y, et al. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor\u2013host interactions. Cancer Metastasis Rev. 2006;25:387\u2013408.","journal-title":"Cancer Metastasis Rev"},{"key":"577_CR26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1600-065X.2008.00615.x","volume":"222","author":"RN Apte","year":"2008","unstructured":"Apte RN, Voronov E. Is interleukin-1 a good or bad \u2018guy\u2019 in tumor immunobiology and immunotherapy? Immunol Rev. 2008;222:222\u201341.","journal-title":"Immunol Rev"},{"key":"577_CR27","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3324\/haematol.11199","volume":"92","author":"D Cilloni","year":"2007","unstructured":"Cilloni D, Martinelli G, Messa F, Baccarani M, Saglio G. Nuclear factor \u03baB as a target for new drug development in myeloid malignancies. Haematologica. 2007;92:1124\u20139.","journal-title":"Haematologica"},{"key":"577_CR28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.16.1.225","volume":"16","author":"S Ghosh","year":"1998","unstructured":"Ghosh S, May MJ, Kopp EB. NF-kappaB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol. 1998;16:225\u201360.","journal-title":"Annu Rev Immunol"},{"key":"577_CR29","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1182\/blood-2005-01-0428","volume":"107","author":"SK Biswas","year":"2006","unstructured":"Biswas SK, Gangi L, Paul S, Schioppa T, Saccani A, Sironi M, et al. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3\/STAT1 activation). Blood. 2006;107:2112\u201322.","journal-title":"Blood"},{"key":"577_CR30","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.exphem.2007.09.007","volume":"35","author":"DB Kerbauy","year":"2007","unstructured":"Kerbauy DB, Deeg HJ. Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome. Exp Hematol. 2007;35:1739\u201346.","journal-title":"Exp Hematol"},{"key":"577_CR31","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/sj.leu.2400654","volume":"11","author":"D Bouscary","year":"1997","unstructured":"Bouscary D, De Vos J, Guesnu M, Jondeau K, Viguier F, Melle J, et al. Fas\/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes. Leukemia. 1997;11:839\u201345.","journal-title":"Leukemia"},{"key":"577_CR32","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood.V98.10.3058","volume":"98","author":"DY Zang","year":"2001","unstructured":"Zang DY, Goodwin RG, Loken MR, Bryant E, Deeg HJ. Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis. Blood. 2001;98:3058\u201365.","journal-title":"Blood"},{"key":"577_CR33","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1182\/blood-2005-04-1424","volume":"106","author":"DM Kerbauy","year":"2005","unstructured":"Kerbauy DM, Lesnikov V, Abbasi N, Seal S, Scott B, Deeg HJ. NF-\u03baB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs). Blood. 2005;106:3917\u201325.","journal-title":"Blood"},{"key":"577_CR34","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/sj.cdd.4401874","volume":"13","author":"T Braun","year":"2006","unstructured":"Braun T, Carvalho G, Fabre C, Grosjean J, Fenaux P, Kroemer G. Targeting NF-\u03baB in hematologic malignancies. Cell Death Differ. 2006;13:748\u201358.","journal-title":"Cell Death Differ"},{"key":"577_CR35","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1182\/blood-2004-04-1463","volume":"105","author":"C Frelin","year":"2005","unstructured":"Frelin C, Imbert V, Griessinger E, Peyron AC, Rochet N, Philip P, et al. Targeting NF-\u03baB activation via pharmacologic inhibition of IKK2 induced apoptosis of human acute myeloid leukaemia cells. Blood. 2005;105:804\u201311.","journal-title":"Blood"},{"key":"577_CR36","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1182\/blood.V98.8.2301","volume":"98","author":"ML Guzman","year":"2001","unstructured":"Guzman ML, Neering SJ, Upchurch D, Grimes B, Howard DS, Rizzieri DA, et al. Nuclear factor-\u03baB is constitutively activated in primitive human acute myelogenous leukaemia cells. Blood. 2001;98:2301\u20137.","journal-title":"Blood"},{"key":"577_CR37","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1038\/sj.leu.2402641","volume":"16","author":"B Baumgartner","year":"2002","unstructured":"Baumgartner B, Weber M, Quirling M, Fischer C, Page S, Adam M, et al. Increased IkappaB kinase activity is associated with activated NF-kappaB in acute myeloid blasts. Leukemia. 2002;16:2062\u201371.","journal-title":"Leukemia"},{"key":"577_CR38","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.humpath.2003.08.020","volume":"35","author":"CE Bueso-Ramos","year":"2003","unstructured":"Bueso-Ramos CE, Rocha FC, Shishodia S, Medeiros LJ, Kantarjian HM, Vadhan-Raj S, et al. Expression of constitutively active nuclear-kB RelA transcription factor in blasts of acute myeloid leukaemia. Hum Pathol. 2003;35:246\u201353.","journal-title":"Hum Pathol"},{"key":"577_CR39","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1101\/gad.12.7.968","volume":"12","author":"JY Reuther","year":"1998","unstructured":"Reuther JY, Reuther GW, Cortez D, Pendergast AM, Baldwin AS Jr. A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation. Genes Dev. 1998;12:968\u201381.","journal-title":"Genes Dev"},{"key":"577_CR40","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0301-472X(03)00069-9","volume":"31","author":"D Kirchner","year":"2003","unstructured":"Kirchner D, Duyster J, Ottmann O, Schmid RM, Bergmann L, Munzert G. Mechanisms of Bcr-Abl-mediated NF-kappB\/Rel activation. Exp Hematol. 2003;31:504\u201311.","journal-title":"Exp Hematol"},{"key":"577_CR41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/qjmed\/93.4.223","volume":"93","author":"G Grateau","year":"2000","unstructured":"Grateau G, Pecheux C, Cazeneuve C, Cattan D, Dervichian M, Goossens M, et al. Clinical versus genetic diagnosis of familial Mediterranean fever. Q J Med. 2000;93:223\u20139.","journal-title":"Q J Med"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-010-0577-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-010-0577-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-010-0577-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T05:15:46Z","timestamp":1591247746000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-010-0577-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,1]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["577"],"URL":"https:\/\/doi.org\/10.1007\/s12185-010-0577-x","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,1]]}}}